LifeStance Health Group, Inc. (LFST) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
LFST EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
LFST Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 28.5% | 1.8% | 0.7% |
| 2024 | 32.2% | -2.5% | -4.6% |
| 2023 | 28.6% | -17.9% | -17.6% |
| 2022 | 27.6% | -24.5% | -25.1% |
| 2021 | 30.2% | -42.9% | -46.0% |
Download Data
Export LFST earnings history in CSV or JSON format
Free sign-in required to download data
LifeStance Health Group, Inc. (LFST) Earnings Overview
As of May 8, 2026, LifeStance Health Group, Inc. (LFST) reported trailing twelve-month net income of $23M, reflecting +113.3% year-over-year growth. The company earned $0.06 per diluted share over the past four quarters, with a net profit margin of 0.7%.
Looking at the long-term picture, LFST's historical earnings data spans multiple years. The company achieved its highest annual net income of $10M in fiscal 2025, representing a new all-time high.
LifeStance Health Group, Inc. maintains positive profitability with a gross margin of 28.5%, operating margin of 1.8%, and net margin of 0.7%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ACHC (-$1.11B net income, -33.3% margin), UHS ($1.52B net income, 8.6% margin), SGRY (-$76M net income, -2.4% margin), LFST has outperformed on profitability metrics. Compare LFST vs ACHC →
LFST Earnings vs Peers
Earnings metrics vs comparable public companies
LFST Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $10M | +116.8% | $26M | $0.02 | 0.7% | 1.8% |
| 2024 | -$57M | +69.2% | -$32M | $-0.15 | -4.6% | -2.5% |
| 2023 | -$186M | +13.6% | -$189M | $-0.51 | -17.6% | -17.9% |
| 2022 | -$216M | +29.8% | -$210M | $-0.61 | -25.1% | -24.5% |
| 2021 | -$307M | -706.9% | -$286M | $-1.05 | -46.0% | -42.9% |
| 2020 | -$38M | -771.5% | $15M | $-0.83 | -10.1% | 4.1% |
| 2019 | $6M | - | $15M | $0.02 | 2.7% | 7.2% |
See LFST's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs LFST Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare LFST vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonLFST — Frequently Asked Questions
Quick answers to the most common questions about buying LFST stock.
Is LFST growing earnings?
LFST EPS is $0.06, with earnings growth accelerating to +113.3%. This exceeds the 5-year CAGR of N/A. TTM net income reached $23M.
What are LFST's profit margins?
LifeStance Health Group, Inc. net margin is +0.7%, with operating margin at +1.8%. Below-average margins reflect competitive or cost pressures.
How consistent are LFST's earnings?
LFST earnings data spans 2019-2025. The accelerating earnings trend is +113.3% YoY. Historical data enables comparison across business cycles.